rs141390544
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_002291.3(LAMB1):c.3038G>A(p.Arg1013Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000384 in 1,614,126 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002291.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMB1 | NM_002291.3 | c.3038G>A | p.Arg1013Gln | missense_variant | 22/34 | ENST00000222399.11 | NP_002282.2 | |
LAMB1 | XM_047420359.1 | c.3038G>A | p.Arg1013Gln | missense_variant | 22/28 | XP_047276315.1 | ||
LAMB1 | XM_047420360.1 | c.3038G>A | p.Arg1013Gln | missense_variant | 22/25 | XP_047276316.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMB1 | ENST00000222399.11 | c.3038G>A | p.Arg1013Gln | missense_variant | 22/34 | 1 | NM_002291.3 | ENSP00000222399.6 |
Frequencies
GnomAD3 genomes AF: 0.000539 AC: 82AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000402 AC: 101AN: 251476Hom.: 0 AF XY: 0.000331 AC XY: 45AN XY: 135914
GnomAD4 exome AF: 0.000368 AC: 538AN: 1461872Hom.: 0 Cov.: 34 AF XY: 0.000392 AC XY: 285AN XY: 727236
GnomAD4 genome AF: 0.000539 AC: 82AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.000604 AC XY: 45AN XY: 74444
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 06, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden | Mar 09, 2022 | PM1, PM2_SUP, PM3, BP4 - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 24, 2015 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 01, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at